Meet GOLD's new catalyst – AZ’s Mina Makar - European Medical Journal

Meet GOLD’s new catalyst – AZ’s Mina Makar

Season 04: episode 02

This week, the team shares a teaser of our latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, which can be found here.

In this special podcast edition of the interview, Mina discusses why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on how to be an effective leader.

A little bit more on GOLD’s guest…

Mina Makar is Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), at AstraZenca. In this role, he is focused on addressing the unmet needs in four inter-related disease areas: metabolism, heart failure, cardiovascular disease and renal diseases, and he is helping to drive AstraZeneca’s ambition to stop, reverse and cure these chronic diseases. He began his 30-year career in healthcare as a pharmacist but left to join pharma early on in his professional journey. He has held roles across medical affairs, sales, marketing and market access over the course of his lengthy career in life sciences.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally